Coleen Glessner

Insider Reports History

Entity
Individual
Location
400 Professional Drive, Suite 400, Gaithersburg, MD
Signature
/s/ Jennifer Lynne Fox, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Coleen Glessner:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Emergent BioSolutions Inc. EVP, Quality & Ethics, and CPL Common Stock 163K $1.01M $6.19 Jun 8, 2024 Direct
Emergent BioSolutions Inc. EVP, Quality & Ethics, and CPL Employee Stock Options (Right to Buy) 187K Mar 13, 2024 Direct
Emergent BioSolutions Inc. EVP, Quality & Ethics, and CPL Employee Stock Option (Right to buy) 62.1K Jun 9, 2023 Direct

Insider Reports Filed by Coleen Glessner

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EBS Emergent BioSolutions Inc. Jun 8, 2024 1 -$7.73K 4 Jun 11, 2024 EVP, Quality & Ethics, and CPL
EBS Emergent BioSolutions Inc. Apr 7, 2024 1 -$1.34K 4 Apr 9, 2024 EVP, Quality & Ethics, and CPL
EBS Emergent BioSolutions Inc. Mar 13, 2024 1 $0 4 Mar 15, 2024 EVP, Quality & Ethics, and CPL
EBS Emergent BioSolutions Inc. Mar 1, 2024 1 -$1.29K 4 Mar 4, 2024 EVP, Quality & Ethics, and CPL
EBS Emergent BioSolutions Inc. Jun 9, 2023 3 $0 4 Jun 13, 2023 EVP, Quality & Ethics, and CPL
EBS Emergent BioSolutions Inc. Apr 7, 2023 1 $0 4 Apr 10, 2023 EVP, Quality & Ethics, and CPL
EBS Emergent BioSolutions Inc. Mar 2, 2023 3 $0 4 Mar 6, 2023 EVP, Quality & Ethics, and CPL
EBS Emergent BioSolutions Inc. Dec 9, 2022 2 $0 4 Dec 13, 2022 EVP, Quality & Ethics, and CPL
EBS Emergent BioSolutions Inc. Apr 8, 2022 3 $1M 4 Apr 12, 2022 EVP, Quality & Ethics, and CPL
EBS Emergent BioSolutions Inc. Mar 14, 2022 0 $0 3 Mar 25, 2022 EVP, Quality & Ethics, and CPL